Navigation Links
Arthritis Foundation Launches "Prescription for Access" Toolkit to Support People With Arthritis by Delivering Resources to Help With Health Coverage and Denied Claims
Date:1/31/2017

ATLANTA, Jan. 31, 2017 /PRNewswire-USNewswire/ -- The pain and management of arthritis may not be visible, but it is incredibly real to the 50 million Americans diagnosed with arthritis and related diseases. Adding to this population's challenges are mounting concerns about the future of America's health care system and how to navigate its complexities. In response to the arthritis community, the Arthritis Foundation launched Prescription for Access, an initiative to address the arthritis community's concerns and provide people with arthritis the necessary tools to help them live a life of Yes.

As part of the Prescription for Access initiative, the Foundation recently held multiple meetings with health care executives, policymakers and patients to better understand the challenges patients with arthritis face in today's health care system. From these meetings, the Foundation believes the most logical way to "re-connect" America's health care system is to involve patients and make sure their voices are represented in the new legislation.

"We're fighting for millions of Americans with arthritis to make health care more accessible and to reduce the complexity of accessing and staying on their medications," said Sandie Preiss, vice president of advocacy and access, Arthritis Foundation. "A critical part of the Prescription for Access initiative is equipping patients with the tools and resources they need to understand their health care and how to get to 'Yes' when managing a claim denial through the appeal process."

The Prescription for Access Toolkit puts the necessary tools and resources right at patients' fingertips. This powerful resource helps patients better understand their health care coverage options, determine how their current plan meets their arthritis care needs as well as guide them through the clam denial process, including step-by-step instructions, sample letters and consumer assistance information.

To learn more about the Prescription for Access initiative, including recent work with government leaders and organizations, please visit www.arthritis.org/prescription-for-access

About the Arthritis Foundation:
The Arthritis Foundation is the Champion of Yes. Leading the fight for the arthritis community, the Foundation helps conquer everyday battles through life-changing information and resources, access to optimal care, advancements in science and community connections. The Arthritis Foundation's goal is to chart a winning course, guiding families in developing personalized plans for living a full life – and making each day another stride toward a cure. The Foundation also publishes Arthritis Today, the award-winning magazine that reaches 4 million readers.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arthritis-foundation-launches-prescription-for-access-toolkit-to-support-people-with-arthritis-by-delivering-resources-to-help-with-health-coverage-and-denied-claims-300398872.html


'/>"/>
SOURCE Arthritis Foundation
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. U.S. FDA Extends Review Period for Baricitinib, an Investigational Rheumatoid Arthritis Treatment
2. Arthritis Foundation to Host Osteoarthritis Patient-Focused Drug Development Meeting
3. Global Rheumatoid Arthritis Partnering 2010 to 2016
4. Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis
5. Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026
6. Prescription Chondroitin Sulphate is as Efficacious as Celecoxib and Better Than Placebo in Knee Osteoarthritis
7. Verschreibungspflichtiges Chondroitinsulfat ist bei Knie-Osteoarthritis genauso wirksam wie Celecoxib und besser als Placebos
8. Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
9. Osteoarthritis Pain Market (Drugs) to Grow at 8.38% CAGR Driven by Emergence of New Treatments to 2020
10. Osteoarthritis Pipeline Market H1 2016 Global Review Report
11. Regeneron and Sanofi Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... Services, Inc. (NYSE: WST ) today announced ... financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record high, ... constant currency (organic) grew by 3.9%. ... in the prior-year quarter. Second-quarter 2017 adjusted diluted EPS ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
(Date:7/25/2017)... -- Debbie,s Dream Foundation: Curing Stomach Cancer (DDF) is excited to host its 3 ... Bonaventure Resort & Spa in Weston, Florida beginning at ... Luncheon Committee Co-chair ... Luncheon Committee Co-chair Sabrina Kurzman. ... Aura Morales-Guzman, Angela Perez, DDF Board Member John ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... The ... for men and women to train as hospice volunteers. Volunteers provide much needed ... For over 30 years, the agency has trained volunteers to be vital members ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin Care ... skincare solutions, recently announced the launch of two new skincare products, Prache Antiaging ... alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache Antiaging ...
(Date:8/16/2017)... ... ... of A Child” is the creation of published author, Pauline DiBenedetto. , “As my mother ... was in such great pain, my mother thought that her time has come. Once I ... I was about eight years old, when I had a vision of my own, that ...
(Date:8/15/2017)... ... ... The first study to report that overall survival was extended for patients receiving ... now published online ahead of print in the Journal of Clinical Oncology, or JCO. ... at Roswell Park Cancer Institute, was principal investigator for one of the three clinical ...
(Date:8/15/2017)... Hills, California (PRWEB) , ... August 15, 2017 ... ... describes the case of a woman who fell into a coma and died ... a plastic surgeon. The procedure was performed in the alleged perpetrator’s apartment after ...
Breaking Medicine News(10 mins):